Sign in

Affirm Holdings, Inc. AFRM

Price 74.1 USD
as of 2026-09-04
48/100
Constructive
Quality50
Growth60
Balance-sheet strength42
Valuation39
Momentum55
Income50

Composite 48/100; the shares have moved about 57% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Valuation ranks 39/100 — a slight mark against it.

Case for

Growth ranks 60/100 — a slight point in its favour. Momentum ranks 55/100 — a slight point in its favour.

Case against

Valuation ranks 39/100 — a slight mark against it. Balance-sheet strength ranks 42/100 — a slight mark against it. Quality ranks 50/100 — a slight mark against it.

What the company does Affirm Holdings operates a U.S.-based point-of-sale payment network enabling consumers to pay over time via merchant partnerships across retail, travel, electronics, and other sectors.

Key financials Revenue grew 32.6% with net margins at 9.6%. ROE is 11.5%, ROA 1.7%, and ROCE 6.4%. Forward P/E is 36.23x and EV/EBITDA 27.28x, with a strong growth score of 90.4.

Stock health Momentum is mixed: +15.39% over 3m but -26.75% below the 52w high; RSI(14) at 46.10 indicates neutral momentum. Piotroski F-Score is 9/9, but Altman Z is 1.98 and interest coverage is 1.90.

Price vs fair value The stock trades at a PREMIUM of 58.60% to our fair-value estimate of 30.33 and a discount of 23.69% to the analyst 12-month target of 90.60. - Analysts question whether rising optimism clarifies Affirm’s earnings power (Simply Wall St.) - Rate cuts could pose both risks and rewards for Affirm’s credit model (Motley Fool) - Recent coverage flags warning signs despite its popularity (StockStory) - Stock fell more steeply than the broader market on July 29 (Zacks)

Looking forward Forward PEG of 0.46 suggests potential value relative to growth, but high leverage (Debt/Equity 2.40) and weak interest coverage warrant caution. Valuation percentile at 23.5/100 underscores rich pricing versus peers.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.